CBD for Health and Well-Being: Prospects and Opportunities
Prospects and Opportunities
In recent years, the availability of plant-based products containing CBD has increased significantly. From oils and tinctures to beverages, edibles, creams and more, CBD appears to be gaining popularity across a wide range of product categories. As interest in natural alternatives continues to grow, it is no surprise that CBD is becoming increasingly widespread.
CBD, also known as cannabidiol, is a compound derived from the cannabis plant and is widely known for its potential anti-inflammatory properties and its possible role in supporting mood and general well-being. As a naturally derived, plant-based compound, CBD has attracted considerable interest as a potential complementary option for conditions such as anxiety, insomnia, chronic pain and even epilepsy. However, the potential applications of CBD are still only beginning to be explored.
Clinical potential for pain and inflammation
The inclusion of CBD as a key ingredient in Fitodenta’s dental surgery oral care products is part of a growing movement towards more targeted and scientifically supported applications of CBD. Despite its widespread availability, relatively few clinical studies have been conducted specifically on CBD. However, existing research, including Fitodenta’s clinical evaluation of its oral spray and topical gel, has contributed to growing interest in the potential applications of CBD.
The potential pain-relieving and anti-inflammatory properties of CBD make it a compound of particular interest in dental care. Studies have investigated the analgesic effects of CBD in various types of pain and inflammation, including acute oedema and chronic arthritis.[1,2] These properties were among the reasons for including CBD in Fitodenta oral care products designed to support patients during recovery following dental procedures.
A clinical evaluation of Fitodenta products indicated that the combined use of a CBD-containing oral spray and topical gel was associated with a rapid reduction in pain and an improvement in recovery time of up to 40% compared with NSAIDs and high-dose antibiotics. These findings contribute to the growing body of research exploring CBD as a potential complementary approach to conventional treatment strategies, alongside evidence suggesting that cannabinoids may have an opioid-sparing potential.[3]
A growing body of CBD research
More research is clearly needed to fully understand the potential benefits and applications of CBD. However, as regulations surrounding the cultivation and processing of cannabis and cannabis extracts evolve worldwide, CBD is increasingly becoming the subject of serious scientific and medical research.
For example, studies have investigated the potential neuroprotective properties of CBD and their possible relevance to conditions such as Alzheimer’s and Parkinson’s disease.[4] Early research has also explored the potential use of CBD as an adjunct to conventional cancer treatment.
In dentistry, CBD is also being investigated as a potential complementary approach to conventional post-operative management involving NSAIDs, opioids and antibiotics. One of the potential advantages of CBD is its generally favourable tolerability profile. Unlike THC, CBD does not produce the intoxicating “high” commonly associated with cannabis. CBD is generally well tolerated, although side effects such as dry mouth and changes in appetite may occur.[5] CBD should, of course, be used in consultation with healthcare professionals to minimise potential risks and support its safe and appropriate use.
References
[1] Zuardi, A.W. (2008). Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action. Rev. Bras. Psiquiatr. 30: 271–280.
[2] Nagarkatti P, Pandey R, Rieder SA, Hegde VL, Nagarkatti M (2009). Cannabinoids as novel anti-inflammatory drugs. Future Med Chem. 1(7): 1333–1349.
[3] Strouse, Thomas (2016). Cannabinoids in medical practice. Cannabis and Cannabinoid Research. 1(1): 40.
[4] Cheng D, Spiro AS, Jenner AM, Garner B, Karl T (2014). Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer’s disease.
[5] Larsen C, Shahinas J (2020). Dosage, efficacy and safety of cannabidiol administration in adults: a systematic review of human trials. J Clin Med Res. 12(3): 129–141.
CBD, also known as cannabidiol, is a compound derived from the cannabis plant and is widely known for its potential anti-inflammatory properties and its possible role in supporting mood and general well-being. As a naturally derived, plant-based compound, CBD has attracted considerable interest as a potential complementary option for conditions such as anxiety, insomnia, chronic pain and even epilepsy. However, the potential applications of CBD are still only beginning to be explored.
Clinical potential for pain and inflammation
The inclusion of CBD as a key ingredient in Fitodenta’s dental surgery oral care products is part of a growing movement towards more targeted and scientifically supported applications of CBD. Despite its widespread availability, relatively few clinical studies have been conducted specifically on CBD. However, existing research, including Fitodenta’s clinical evaluation of its oral spray and topical gel, has contributed to growing interest in the potential applications of CBD.
The potential pain-relieving and anti-inflammatory properties of CBD make it a compound of particular interest in dental care. Studies have investigated the analgesic effects of CBD in various types of pain and inflammation, including acute oedema and chronic arthritis.[1,2] These properties were among the reasons for including CBD in Fitodenta oral care products designed to support patients during recovery following dental procedures.
A clinical evaluation of Fitodenta products indicated that the combined use of a CBD-containing oral spray and topical gel was associated with a rapid reduction in pain and an improvement in recovery time of up to 40% compared with NSAIDs and high-dose antibiotics. These findings contribute to the growing body of research exploring CBD as a potential complementary approach to conventional treatment strategies, alongside evidence suggesting that cannabinoids may have an opioid-sparing potential.[3]
A growing body of CBD research
More research is clearly needed to fully understand the potential benefits and applications of CBD. However, as regulations surrounding the cultivation and processing of cannabis and cannabis extracts evolve worldwide, CBD is increasingly becoming the subject of serious scientific and medical research.
For example, studies have investigated the potential neuroprotective properties of CBD and their possible relevance to conditions such as Alzheimer’s and Parkinson’s disease.[4] Early research has also explored the potential use of CBD as an adjunct to conventional cancer treatment.
In dentistry, CBD is also being investigated as a potential complementary approach to conventional post-operative management involving NSAIDs, opioids and antibiotics. One of the potential advantages of CBD is its generally favourable tolerability profile. Unlike THC, CBD does not produce the intoxicating “high” commonly associated with cannabis. CBD is generally well tolerated, although side effects such as dry mouth and changes in appetite may occur.[5] CBD should, of course, be used in consultation with healthcare professionals to minimise potential risks and support its safe and appropriate use.
References
[1] Zuardi, A.W. (2008). Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action. Rev. Bras. Psiquiatr. 30: 271–280.
[2] Nagarkatti P, Pandey R, Rieder SA, Hegde VL, Nagarkatti M (2009). Cannabinoids as novel anti-inflammatory drugs. Future Med Chem. 1(7): 1333–1349.
[3] Strouse, Thomas (2016). Cannabinoids in medical practice. Cannabis and Cannabinoid Research. 1(1): 40.
[4] Cheng D, Spiro AS, Jenner AM, Garner B, Karl T (2014). Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer’s disease.
[5] Larsen C, Shahinas J (2020). Dosage, efficacy and safety of cannabidiol administration in adults: a systematic review of human trials. J Clin Med Res. 12(3): 129–141.
Share: